greater/proline

FIELD OF THE INVENTION The present invention relates to the field of chiral chemistry. More particularly, the present invention relates to the separation of enantiomers, i.e., those isomers in which the arrangement of atoms or groups is such that the two molecules are not superimposable. The present

BACKGROUND OF THE INVENTION This invention relates to an improved fermentation process for producing angiotensin I converting enzyme inhibitor A-58365 factor B. In particular, it relates to an improved fermentation process for producing A-58365 factor B which comprises culturing Streptomyces

REFERENCE TO A "SEQUENCE LISTING," A TABLE, OR A COMPUTER PROGRAM LISTING APPENDIX SUBMITTED AS AN ASCII TEXT FILE The Sequence Listing written in file -13-1.TXT, created on Oct. 23, 2013, 184,320 bytes, machine format IBM-PC, MS-Windows operating system, is hereby incorporated by reference in its

FIELD OF THE INVENTION This invention relates to an enzyme and its use, for example in preparing (S)-pipecolic acid. BACKGROUND OF THE INVENTION (S)-Pipecolic acid is an intermediate in the preparation of levobupivacaine, the less cardiotoxic enantiomer of the analgesic and anaesthetic agent

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to a new pharmaceutical composition useful for the treatment of pyrexia and inflammation. More particularly, this invention relates to a tripeptide sequence contained in alpha-Melanocyte Stimulating Hormone and ACTH which

1. FIELD OF THE INVENTION This invention relates to a new pharmaceutical composition useful for the treatment of pyrexia and inflammation. More particularly, this invention relates to a tripeptide sequence contained in alpha-Melanocyte Stimulating Hormone and ACTH which has been identified as an

BACKGROUND OF THE INVENTION The construction of a fusion protein involves the linking of two proteins or domains of proteins by a peptide linker. Selection of an appropriate linker sequence is important, as it can affect the function and physical properties of the resulting fusion protein. Often

SEQUENCE LISTING The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy, created on May 31, 2013, is named 4000.3060WO_SL.txt and is 38,144 bytes in size. BACKGROUND OF THE

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to linked fusion polypeptides derived from single and multiple chain proteins. In particular, the invention relates to the linker peptide essential for bridging the polypeptide constituents that comprise the linked

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to linked fusion polypeptides derived from single and multiple chain proteins. In particular, the invention relates to the linker peptide essential for bridging the polypeptide constituents that comprise the linked

BACKGROUND OF THE INVENTION Field of the Invention The invention relates to an anti-tumor polypeptide and a method for preparing an anti-tumor drug comprising the same. Description of the Related Art JWA gene, also known as ARL6IP5 (GenBank: AF070523.1, 1998; LOCUS: AF070523, NM_00640) was initially

This invention relates to antibiotic substances, a process for the preparation and compositions thereof and methods of treatment therewith. The invention further relates to a new strain of Staphylococcus epidermidis which produces the antibiotic substances, compositions, containing the said strain

BACKGROUND OF THE INVENTION 1. Field of the Invention Applicants' invention relates to the field of tumor growth regulation. More particularly, Applicants' invention concerns unique non-mammalian peptide hormone analogs of non-mammalian gonadotropin releasing hormone (GnRH) and the method for use of

This invention relates to antibiotic substances, a process for the preparation and compositions thereof and methods of treatment therewith. The invention further relates to a new strain of Staphylococcus epidermidis which produces the antibiotic substances, compositions, containing the said strain

FIELD OF THE INVENTION The present invention relates generally to the field of regulating fertility and parturition. More particularly, it concerns the use of unique non-mammalian peptide hormone analogs of GnRH designed to be useful in fertility regulation, post-coital contraception and as a